Falipamil (AQ‐A 39) and UL‐FS 49
- 1 March 1988
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 6 (1) , 35-53
- https://doi.org/10.1111/j.1527-3466.1988.tb00371.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Specific Bradycardic Agents, A New Therapeutic Modality for AnesthesiologyAnesthesiology, 1987
- Effects of the bradycardic agent UL-FS 49 on exercise-induced regional contractile dysfunction in dogsInternational Journal of Cardiology, 1987
- The cardiac hyperpolarizing-activated current, if. origins and developmentsProgress in Biophysics and Molecular Biology, 1985
- Actions of Two New Bradycardic Agents, AQ-AH 208 and UL-FS 49, on Ischemic Myocardial Perfusion and FunctionJournal of Cardiovascular Pharmacology, 1985
- Comparison of Cardiovascular Responses to the Bradycardic Drugs, Alinidine, AQ-A 39, and Mixidine, in the Anesthetized DogJournal of Cardiovascular Pharmacology, 1984
- A Classification of Antiarrhythmic Actions Reassessed After a Decade of New DrugsThe Journal of Clinical Pharmacology, 1984
- Molecular Pharmacology of the Calcium ChannelJournal of Cardiovascular Pharmacology, 1984
- Actions of Alinidine and AQ-A 39 on Rate and Contractility of Guinea Pig Atria During β-Adrenoceptor StimulationJournal of Cardiovascular Pharmacology, 1983
- AQ-A 39 (5,6-dimethoxy-2-[3[[α-(3,4-dimethoxy)-phenyl-ethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heartEuropean Journal of Pharmacology, 1981
- Indirect assessment of myocardial oxygen consumption in the evaluation of mechanisms and therapy of angina pectorisThe American Journal of Cardiology, 1974